• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心肾综合征:临床结局研究。

Cardiorenal Syndrome: Clinical Outcome Study.

作者信息

Shah H R, Singh N P, Aggarwal N P, Singhania D, Kumar A

机构信息

DNB Resident, Dept. of Medicine.

Director, Meedicine Allied Specialities.

出版信息

J Assoc Physicians India. 2016 Dec;64(12):41-46.

PMID:28405987
Abstract

BACKGROUND

Over recent years, the field of medicine has been challenged by the twin epidemic of heart failure and renal insufficiency. The coexistence of the two problems in the same patient, referred to as cardiorenal syndrome (CRS), is defined as 'disorders of the heart and kidneys whereby acute or chronic dysfunction in one organ may induce acute or chronic dysfunction of the other. The mechanisms underlying this interaction are complex and multifactorial in nature.

OBJECTIVE OF STUDY

Identify and classify patients admitted with cardiorenal syndrome into various subtypes and assess clinical outcome at discharge and at three months.

METHODS

Ours was a longitudinal study of 50 patients admitted in ICU with CRS. They were classified as per RONCO classification (2008) into various subtypes. Outcomes was addressed as favourable for patients stable at discharge and at 3 months follow up, whereas outcome was termed non-favourable for patients who expired or initiated on hemodialysis.

RESULTS

Of 50 patients, two-third patients were males (66%), with mean age of males and females being 64.18 years and 64.64 years respectively. Majority of the patients had Type-1 CRS (46%) followed by twenty two percent Type-2, twenty six percent type-4 and six percent Type-5. There were no patients with type-3 CRS. At the end of the study, 24 (48%) patients were stable, 12 (24%) required dialysis and 14 (28%) patients had expired. The total non-favourable outcomes (dialysis / death) were higher with subtypes CRS-4 (n-11, 22%) and CRS-1 (n-8, 16%). Anemia, raised serum creatinine, low eGFR values, low ejection fraction were significant predictors of non-favourable outcome in our study.

CONCLUSIONS

CRS occurs in all age groups, more commonly in elderlies with a male preponderance. Prevalence of CRS-1 was higher followed by CRS-4. Prognosis was unfavourable in CRS-1, CRS-4 and CRS-5. Sepsis was predominant cause of death in patients with CRS-5 with hundred percent mortality during hospital stay. Risk factors like pre-existing renal impairment, anemia, reduced e GFR and low ejection fraction were significantly associated with worse outcomes. There is need for large scale population / community based studies to chart the prevalence of cardiorenal subtypes and prognosticate each individually.

摘要

背景

近年来,医学领域受到心力衰竭和肾功能不全这两大流行病的挑战。同一患者中这两个问题并存,即心肾综合征(CRS),被定义为“心脏和肾脏的紊乱,其中一个器官的急性或慢性功能障碍可能导致另一个器官的急性或慢性功能障碍。这种相互作用的机制本质上是复杂且多因素的。

研究目的

识别并将因心肾综合征入院的患者分类为不同亚型,并评估出院时和三个月时的临床结局。

方法

我们对50例因CRS入住重症监护病房的患者进行了一项纵向研究。根据RONCO分类(2008年)将他们分为不同亚型。对于出院时和3个月随访时病情稳定的患者,结局被视为良好,而对于死亡或开始进行血液透析的患者,结局被称为不良。

结果

50例患者中,三分之二为男性(66%),男性和女性的平均年龄分别为64.18岁和64.64岁。大多数患者为1型CRS(46%),其次是22%的2型、26%的4型和6%的5型。没有3型CRS患者。在研究结束时,24例(48%)患者病情稳定,12例(24%)需要透析,14例(28%)患者死亡。CRS-4(n = 11,22%)和CRS-1(n = 8,16%)亚型的总不良结局(透析/死亡)更高。贫血、血清肌酐升高、估算肾小球滤过率(eGFR)值低、射血分数低是我们研究中不良结局的重要预测因素。

结论

CRS发生于所有年龄组,更常见于老年人,男性居多。CRS-1的患病率最高,其次是CRS-4。CRS-1、CRS-4和CRS-5的预后不良。脓毒症是CRS-5患者死亡的主要原因,住院期间死亡率为100%。既往存在的肾功能损害、贫血、eGFR降低和射血分数低等危险因素与更差的结局显著相关。需要进行大规模的基于人群/社区的研究,以绘制心肾亚型的患病率并分别预测每种亚型的预后。

相似文献

1
Cardiorenal Syndrome: Clinical Outcome Study.心肾综合征:临床结局研究。
J Assoc Physicians India. 2016 Dec;64(12):41-46.
2
Cardiorenal syndrome.心肾综合征
Heart Fail Clin. 2014 Apr;10(2):251-80. doi: 10.1016/j.hfc.2013.12.003. Epub 2014 Feb 4.
3
Cardiorenal syndrome: a complex series of combined heart/kidney disorders.心肾综合征:一系列复杂的心脏/肾脏联合病症。
Contrib Nephrol. 2011;174:33-45. doi: 10.1159/000329233. Epub 2011 Sep 9.
4
Cardiorenal syndrome in critical care: the acute cardiorenal and renocardiac syndromes.危重病中心力肾综合征:急性心肾和肾心综合征。
Adv Chronic Kidney Dis. 2013 Jan;20(1):56-66. doi: 10.1053/j.ackd.2012.10.005.
5
Cardiorenal syndrome type 4: A study of cardiovascular diseases in chronic kidney disease.4型心肾综合征:慢性肾脏病中的心血管疾病研究
Indian Heart J. 2017 Jan-Feb;69(1):11-16. doi: 10.1016/j.ihj.2016.07.006. Epub 2016 Jul 15.
6
Diabetes prevalence and outcomes in hospitalized cardiorenal-syndrome patients with and without hyponatremia.合并或不合并低钠血症的住院心肾综合征患者的糖尿病患病率和结局。
BMC Nephrol. 2020 Sep 10;21(1):393. doi: 10.1186/s12882-020-02032-z.
7
Inotropes and cardiorenal syndrome in acute heart failure - A retrospective comparative analysis.急性心力衰竭中的正性肌力药物与心肾综合征——一项回顾性对比分析
Rev Port Cardiol. 2017 Sep;36(9):619-625. doi: 10.1016/j.repc.2017.03.006. Epub 2017 Aug 18.
8
[Cardiorenal syndrome type 1 in the intensive coronary care unit of the Hospital Nacional Arzobispo Loayza].[洛亚萨大主教国家医院重症冠心病监护病房中的1型心肾综合征]
Arch Cardiol Mex. 2015 Jul-Sep;85(3):176-87. doi: 10.1016/j.acmx.2015.05.004. Epub 2015 Jul 8.
9
Clinical outcomes and 30-day readmissions for heart failure with reduced ejection fraction with cardiorenal syndrome: A National Cohort Study.射血分数降低的心力衰竭合并心肾综合征的临床结局及30天再入院情况:一项全国队列研究
Int J Cardiol. 2023 Jan 1;370:244-249. doi: 10.1016/j.ijcard.2022.10.161. Epub 2022 Oct 31.
10
Biomarkers for acute cardiorenal syndrome.急性心肾综合征的生物标志物
Nephrology (Carlton). 2018 Oct;23 Suppl 4:68-71. doi: 10.1111/nep.13473.

引用本文的文献

1
Febuxostat therapy improved the outcomes of cardiorenal syndrome rodent through alleviating xanthine oxidase-induced oxidative stress and mitochondrial dysfunction.非布司他治疗通过减轻黄嘌呤氧化酶诱导的氧化应激和线粒体功能障碍改善了心肾综合征啮齿动物的预后。
Int J Biol Sci. 2025 Feb 10;21(4):1749-1766. doi: 10.7150/ijbs.99194. eCollection 2025.
2
A comprehensive review of acute cardio-renal syndrome: need for novel biomarkers.急性心肾综合征的全面综述:对新型生物标志物的需求
Front Pharmacol. 2023 May 23;14:1152055. doi: 10.3389/fphar.2023.1152055. eCollection 2023.
3
Risk factors and outcome variables of cardiorenal syndrome type 1 from the nephrologist's perspective.
从肾脏病学家角度看1型心肾综合征的危险因素及结局变量
Int Urol Nephrol. 2022 Jul;54(7):1591-1601. doi: 10.1007/s11255-021-03036-w. Epub 2021 Oct 28.
4
Prevalence, types, risk factors, and outcomes of cardiorenal syndrome in a rural population of central India: A cross-sectional study.印度中部农村人口中心肾综合征的患病率、类型、危险因素及结局:一项横断面研究。
J Family Med Prim Care. 2020 Aug 25;9(8):4127-4133. doi: 10.4103/jfmpc.jfmpc_533_20. eCollection 2020 Aug.